naltrexone has been researched along with Acquired Immune Deficiency Syndrome in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batki, SL; Coffin, P; DeMartini, A; Euren, J; Hahn, JA; Huffaker, S; Matheson, T; Rowe, C; Santos, D; Santos, GM; Vittinghoff, E; Vlahov, D | 1 |
| Chawarski, M; Mazlan, M; Ng, N; Ruger, JP; Schottenfeld, R | 1 |
| Galasso, FL; Israel, RJ; Moehl Boatwright, ML; Portenoy, RK; Stambler, N; Thomas, J; Tran, D; Von Gunten, CF | 1 |
| Gerada, C; Kemp, K; Smith, P | 1 |
| Bihari, B | 1 |
| Mahayni, H; Minor, JR | 1 |
| Schuster, CR; Snyder, M | 1 |
| Williams, A | 1 |
1 review(s) available for naltrexone and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
An addict who wants to detoxify.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clonidine; Heroin Dependence; Humans; Jaundice; Male; Naltrexone; Needle Sharing; Serologic Tests | 1998 |
4 trial(s) available for naltrexone and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Feasibility, Acceptability, and Tolerability of Targeted Naltrexone for Nondependent Methamphetamine-Using and Binge-Drinking Men Who Have Sex with Men.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Binge Drinking; Condoms; Counseling; Double-Blind Method; Homosexuality, Male; Humans; Male; Methamphetamine; Middle Aged; Naltrexone; Narcotic Antagonists; Placebos; Risk Reduction Behavior; Risk-Taking; Sexual Behavior; Substance-Related Disorders; Unsafe Sex; Young Adult | 2016 |
Cost-effectiveness of buprenorphine and naltrexone treatments for heroin dependence in Malaysia.
Topics: Acquired Immunodeficiency Syndrome; Buprenorphine; Cost-Benefit Analysis; Heroin Dependence; Humans; Malaysia; Naltrexone; Risk Factors; Risk-Taking; Treatment Outcome | 2012 |
Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Diarrhea; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Neoplasms; Pain; Pain Measurement; Quaternary Ammonium Compounds; Terminal Care | 2008 |
Antiretroviral activity of naloxone and naltrexone.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; HIV-1; Humans; Killer Cells, Natural; Naloxone; Naltrexone | 1991 |
4 other study(ies) available for naltrexone and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV/AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Humans; Naltrexone | 1995 |
L-methionine and naltrexone for insomnia.
Topics: Acquired Immunodeficiency Syndrome; Amino Acids, Essential; Complementary Therapies; Humans; Killer Cells, Natural; Methionine; Naltrexone; Narcotic Antagonists; Sleep Initiation and Maintenance Disorders | 1998 |
NIDA's Medication Development Program--1989.
Topics: Acquired Immunodeficiency Syndrome; Brain; Cocaine; Drug and Narcotic Control; Female; Heroin Dependence; Humans; Infant, Newborn; Methadone; Methadyl Acetate; Naltrexone; Pregnancy; Psychotropic Drugs; Research Support as Topic; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders | 1989 |
Primary care of parenteral substance abusers.
Topics: Acquired Immunodeficiency Syndrome; Administration, Intranasal; Antibodies, Viral; Body Weight; Cocaine; Female; Heart Diseases; Hepatitis; Heroin Dependence; HIV Antibodies; Humans; Injections, Intradermal; Injections, Intravenous; Kidney Diseases; Male; Menstruation Disturbances; Methadone; Naltrexone; Nervous System Diseases; Primary Health Care; Respiratory Tract Diseases; Substance-Related Disorders | 1986 |